GLABF (Gemina Laboratories) Payments of Debt: $-0.05 Mil (TTM As of Oct. 2025)


What is Gemina Laboratories Payments of Debt?

Gemina Laboratories GLABF -27.59% Payments of Debt is $-0.05 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's Payments of Debt for the three months ended in Oct. 2025 was $-0.03 Mil.

Gemina Laboratories's Payments of Debt for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.05 Mil.

Gemina Laboratories Payments of Debt Related Terms

Gemina Laboratories Payments of Debt Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Payments of Debt Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Payments of Debt
0.00 -0.05 -0.05 -0.07 -0.08

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.01 0.00 -0.03

Gemina Laboratories Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-0.05 Mil mean?
Gemina Laboratories (GLABF) has a Payments of Debt of $-0.05 Mil as of Oct. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Payments of Debt too high?
Gemina Laboratories' current Payments of Debt is $-0.05 Mil.
How does Gemina Laboratories' Payments of Debt compare to VRTX and REGN?
Gemina Laboratories' Payments of Debt of $-0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Payments of Debt is $-0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Payments of Debt of $-0.05 Mil. The current Payments of Debt is $-0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Payments of Debt is $-0.05 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.